Posts tagged “Metabolon”
Essex Woodlands, a $2.5 billion equity investment firm, is taking a $15 million stake in RTP-based Metabolon, which focuses on the growing field of metabolomics. Another $10 million can be used to buy shares of earlier investors.
Triangle neighbors Muses Labs, which focuses on Azlehimer's, and Metabolon are teaming up to see if they can unlock some of the secrets surrounding Alzheimer's disease. Plus: What is the MEND Protocol Muses has already developed for Alzheimer's?
In our latest wrapup of Triangle headlines from other publications, catch up on reports about the new Fortune 500 and what North Carolina firms made it as well as news about Time Warner Cable, Metabolon and an investigation into H-1B visas in Charlotte.
Metabolon names new exec; Rocky Mount getting new Internet service? Google fiber on Raleigh city agenda
In today's Bulldog update of technology news: Metabolon names new chief commercial officer; Rocky Mount and Suddenlink to offer next gen Internet; how many angel investors are too many?; Google fiber on Raleigh city agenda.
Triangle-based Metabolon, which recently struck a deal with DNA pioneer Craig Venter to help us find ways to live longer, has another high-profile partner: GlaxoSmithKline. The two neighbors disclosed a new collaboration agreement Tuesday.
J. Craig Venter, the man who raced the U.S. government to sequence the first human genome, has a new goal: Help everyone live to 100, in good health. And one of his first partners is RTP-based Metabolon, where he serves as a scientific adviser.
Metabolon will utilize its proprietary molecular technology to help Human Longevity Inc., the new company led by genome pioneer Craig Venter, to find indications of disease and gene mutations.
Raleigh M2M firm sold; Metabolon's new deal; Red Hat expands 'cloud;' FDA nod for OxyBio; Pozen cuts losses; reboot costs TransEnterix
In today's Bullbog blog rounding up the latest tech and life science news: Raleigh-based Jazz Wireless is sold; Metabolon makes a deal with Craig Venter firm; Red Hat joins AWS GovCloud; Oxygen Biotherapeutics can advance research on brain treatment; Pozen cuts its losses; and TransEnterix losses mount as company reboots.
Metabolon, whose proprietary technology has applications in medical diagnostics as well as food and nutrition, is getting a financial boost from two new investors as well as six existing ones in its new round of funding.
Startup Brevado was running out of money when an advisor gave the team one week to remake the business. Read how they did it and made it to a launch today.
Metabolon is the bloodhound of biotech and the 13-Research Triangle Park company is poised to take home a lot more bones from sales of its hot products, writes the N.C. Biotech Center's Jim Shamp.
Metabolon's Prostarix will be marketed by Bostwick Laboratories, giving Metabolon access to one of the largest urology networks in the country.
Food and nutrition research at the David H. Murdock Research Institute is getting a boost through a new partnership with Research Triangle Park metabolomics company Metabolon.
Even before the U.S. Supreme Court decision disallowed human gene patents, biotechnology companies shifted their strategies. Learn how biotechs adjusted.